Financials
Financial year 2025
ENDODERM from Pont-à-Celles, company number BE0655942209, closed financial year 2025 with a result of € 199,187 after tax. For that financial year ENDODERM recorded revenue of € 744,092 and equity of € 518,959. Compared with financial year 2024, the result moved from € 40,577 to € 199,187. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.
€ 518,959
▼ 24% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 199,187
▲ € 158,610 vs 2024
Profit after tax over the fiscal year.
€ 451,957
▲ 15% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 359,194 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 31,688
▼ 34% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 449,547
▲ 10% vs 2024
€ 81,364 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 1,166
▼ 10% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 8,000
▼ 54% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 646,286 | € 524,749 | € 582,831 | € 744,092 | ▲ 28% |
| Gross margin | € 289,147 | € 172,763 | € 132,327 | € 354,931 | ▲ 168% |
| Profit after taxes | € 160,379 | € 79,253 | € 40,577 | € 199,187 | ▲ € 158,610 |
| Equity | € 739,934 | € 779,187 | € 678,966 | € 518,959 | ▼ 24% |
| Total debts | € 204,681 | € 182,108 | € 427,417 | € 677,461 | ▲ 59% |
| Cash | € 583,759 | € 621,630 | € 392,747 | € 451,957 | ▲ 15% |
| Land & buildings | € 112,909 | € 103,176 | € 421,130 | € 411,173 | ▼ 2% |
| Retained profit | € 721,334 | € 760,587 | € 660,366 | € 500,359 | ▼ 24% |
| Dividend | € 37,647 | € 40,000 | € 140,798 | € 359,194 | ▲ 155% |
| Bank debt | € 152,545 | € 122,759 | € 408,615 | € 449,547 | ▲ 10% |
| Balance sheet total | € 944,615 | € 961,296 | € 1,106,383 | € 1,196,421 | ▲ 8% |
Key figures of ENDODERM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ENDODERM?
What happened at ENDODERM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 199,187 (▲ € 158,610 vs 2024). Source: NBB ↗
- New establishment in Pont-à-Celles. KBO
- Start of the company according to the CBE. KBO
In short
From € 160,379 profit in 2022 to € 199,187 profit in 2025.
Paid € 203,893 in corporate taxes since 2022.
Best year ever: 2025, with € 199,187 profit.
Paid out € 577,639 in dividends to the owners in total.
Management
Behind ENDODERM are CAROLE BOURMORCK and TANGUY METZ.
Directors
According to the 2025 annual accounts
CAROLE BOURMORCK
Administrator-manager
TANGUY METZ
Administrator-manager
Establishments
Establishment units
Physical locations of this company
Rue de Seneffe(OB) 3
6230 Pont-à-Celles
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0655.942.209
- VAT number
- BE 0655.942.209
- Registered office
- Rue de Seneffe(OB) 3, 6230 Pont-à-Celles
- Names & denominations
- ENDODERM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 June 2016
- Peppol
- Active · Active since 28 Feb 2026
- Activities · NACE
Activiteiten van medisch specialisten